Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 7/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.32 |
| ▸ | KDM1A | O60341 | 1/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7229548 | 0.90 | SLC6A3 (0.32) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL7233453 | 0.89 | SLC6A3 (0.32) | SLC6A3SLC6A4 | |
| SCHEMBL7222942 | 0.86 | KDM1A (0.32) | SLC6A3SLC6A4SLC6A2KDM1A | |
| SCHEMBL7226769 | 0.86 | SLC6A3 (0.31) | SLC6A3SLC6A4SLC6A2KDM1A | |
| SCHEMBL7233115 | 0.85 | SLC6A3 (0.31) | SLC6A3SLC6A4SLC6A2KDM1ACHRNA7 | |
| SCHEMBL7226161 | 0.85 | SLC6A3 (0.36) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL7224622 | 0.85 | CHRNA7 (0.37) | SLC6A3SLC6A4SLC6A2KDM1ACHRNA7 | |
| SCHEMBL7226147 | 0.84 | SLC6A3 (0.39) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL7225471 | 0.84 | SLC6A3 (0.33) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL7233882 | 0.84 | SLC6A3 (0.33) | SLC6A3SLC6A4SLC6A2KDM1ACHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6562816-B2 | Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects | PHARMACIA & UPJOHN COMPANY | 2003-05-13 | — | — | US | claimed |
| US-6562816-B2 | Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects | PHARMACIA & UPJOHN COMPANY | 2003-05-13 | — | — | US | disclosed |